Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 5/20 | 0.31 |
| ▸ | MAOB | P27338 | 5/20 | 0.31 |
| ▸ | KDM1A | O60341 | 4/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24017021 | 0.76 | TSHR (0.42) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL12327931 | 0.72 | TSHR (0.39) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL12295813 | 0.67 | EPHX1 (0.39) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL3644410 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL12914371 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL270441 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL63809 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL1199046 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL1103798 | 0.66 | EPHX1 (0.52) | TSHREPHX1CYP2C19MEN1KMT2A | |
| SCHEMBL6571126 | 0.66 | TSHR (0.48) | TSHREPHX1CYP2C19MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392504-A4 | SENSOR SURFACES FOR DETECTING ANALYTES | AGILENT TECHNOLOGIES INC (US) | 2008-03-05 | — | — | EP | disclosed |
| US-7208322-B2 | Sensor surfaces for detecting analytes | AGILENT TECHNOLOGIES, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-7179659-B2 | Detection of preferential particles in sample; obtain sample, incubate with sensor and substrate, monitor and measure response, evaluate for presence of particle | AGILENT TECHNOLOGIES, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| EP-1392504-A1 | SENSOR SURFACES FOR DETECTING ANALYTES | Prolinx Incorporated (US) | 2004-03-03 | — | — | EP | disclosed |
| US-6630577-B2 | Useful for producing bioconjugates | PROLINX, INC. | 2003-10-07 | — | — | US | disclosed |
| US-20030032202-A1 | Sensor surfaces for detecting analytes and methods of use | PROLINX INCORPORATED (US) | 2003-02-13 | — | — | US | disclosed |
| US-20020192722-A1 | Sensor surfaces for detecting analytes | PROLINX INCORPORATED (US) | 2002-12-19 | — | — | US | disclosed |
| EP-1264833-A2 | 1,2-Phenylenediboronic acid reagents and complexes | PROLINX, INC. (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002078947-A1 | SENSOR SURFACES FOR DETECTING ANALYTES | PROLINX INCORPORATED (US) | 2002-10-10 | — | — | WO | disclosed |
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | PROLINX, INC. | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020038004-A1 | 1,2-phenylenediboronic acid reagents and complexes | BCR, MGST1, SULT1E1 | TSHR 775/4885EPHX1 1159/4885CYP2C19 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.